Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration: Randomized Controlled Trial

NCT01675895 is registered in ClinicalTrials.gov with Diskapi Teaching and Research Hospital as lead sponsor.

NCT NCT01675895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01675895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration: Randomized Controlled Trial
Lead sponsor
Diskapi Teaching and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
July 31, 2011
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate hyperplasia